Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling final rule

This article was originally published in The Tan Sheet

Executive Summary

To be released in the spring, Procter & Gamble Regulatory Affairs Manager Oral Care OTCs Chris Moorman predicts. Her "best guess" is based on "little signals...in talking with different folks at the agency." The proposed rule was published in February 1997 ("The Tan Sheet" March 3, 1997, pp. 1-9). Moorman says the final rule is "completely drafted" and has been reviewed by FDA legal counsel. "The agency is working this...in tandem with everyone who needs to sign off within the FDA before it goes to [the Office of Management & Budget]," she tells the Regulatory Affairs Professional Society annual conference in Washington, D.C. Oct. 26-28
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089029

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel